Hannah Banach
Family · Waycross, GANPI 1255947610
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Novo Nordisk accounts for 87.7% of it on its own, with 55 other manufacturers making up the rest. 2025 is the largest year on record at $25,848, more than ten times the $1,976 reported in 2021. Among family clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 705 payments — averaging $120.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$75K
- AbbVie$2K
- Lilly USA, LLC$631
- Otsuka America Pharmaceutical, Inc.$610
- AstraZeneca$603
- Pfizer$579
- plus $6K from 50 others
What the payments were for
- Speaking & faculty fees$43,57151%
- Travel & lodging$27,93733%
- Food & beverage$13,58516%
- Education$780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$85,171 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 258 | $321,975 |
| OzempicSemaglutide | 130 | $168,799 |
| VraylarCariprazine Hcl | 84 | $121,535 |
| RexultiBrexpiprazole | 39 | $62,084 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 67 | $58,733 |
| EliquisApixaban | 58 | $56,293 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 68 | $52,334 |
| LinzessLinaclotide | 68 | $51,939 |
| JardianceEmpagliflozin | 69 | $48,048 |
| Repatha SureclickEvolocumab | 47 | $32,502 |
| MyrbetriqMirabegron | 28 | $21,880 |
| TrulicityDulaglutide | 19 | $20,345 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $19,648 |
| BelsomraSuvorexant | 38 | $19,103 |
| Nurtec OdtRimegepant Sulfate | 17 | $18,214 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $631 | $342,320277 claims |
| AbbVieVraylar, Linzess, Ubrelvy | $1,666 | $190,100163 claims |
| Novo NordiskOzempic | $74,700 | $168,799130 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $603 | $81,827102 claims |
| PfizerEliquis, Nurtec Odt | $579 | $74,50775 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $610 | $62,08439 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $247 | $56,91485 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $293 | $56,19779 claims |
| Astellas Pharma US IncMyrbetriq | $203 | $21,88028 claims |
| MerckBelsomra | $259 | $19,10338 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $61 | $15,31920 claims |
| Antares Pharma, Inc.Xyosted | $80 | $12,93419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.
Other family in Waycross
- Tiffany HarkleroadWaycross$16K
- Morgan EldridgeWaycross$15K
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.